fluorescein-5-isothiocyanate has been researched along with Ovarian Neoplasms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.45) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 9 (29.03) | 29.6817 |
| 2010's | 14 (45.16) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, TM; Bremer, E; Eggleton, P; Michalak, M; Slibinskas, R; Whatmore, J | 1 |
| Astilean, S; Borlan, R; Florea, A; Focsan, M; Maniu, D; Marc, G; Soritau, O; Tatar, AS | 1 |
| Elrington, SA; Hasan, T; Mir, Y | 1 |
| Bai, MY; Liu, SZ | 1 |
| Bochner, F; Fellus-Alyagor, L; Kalchenko, V; Neeman, M; Shinar, S | 1 |
| Birngruber, R; Hasan, T; Hüttmann, G; Rahmanzadeh, R; Tangutoori, S; Vogel, A; Wang, S; Zhang, Z | 1 |
| Anvari, B; Bahmani, B; Guerrero, YA; Kundra, V; Singh, SP; Vullev, VI | 1 |
| Ari, K; Ichedef, C; Kilcar, AY; Medine, EI; Teksoz, S; Ucar, E; Yilmaz, B | 1 |
| Bosse, T; Burggraaf, J; Cohen, AF; de Kroon, CD; Gaarenstroom, KN; Hoogstins, CE; Low, PS; Smit, VT; Tummers, QR; Vahrmeijer, AL; van de Velde, CJ; van Poelgeest, MI; Vuyk, J | 1 |
| David, A; Feinshtein, V; Golan, M | 1 |
| Amato, RJ; Hartmann, LC; He, W; Kalli, KR; Klee, GG; Kularatne, SA; Low, PS; Prendergast, FG | 1 |
| Chen, MT; Gomez, LM; Gundersen, MA; Ishikawa, FN; Vernier, PT; Zhou, C | 1 |
| Tang, B; Tong, L; Wu, C; Xu, QH; Zhang, R | 1 |
| Benigno, BB; Dickerson, EB; McDonald, JF; Scarberry, KE; Zhang, ZJ | 1 |
| Fan, M; Murdoch, WJ; Radosz, M; Shen, Y; Sui, M; Tang, J; Van Kirk, EA; Xu, P; Zhou, Z | 1 |
| Baron-Lühr, B; Celli, JP; Gerdes, J; Hasan, T; Rahmanzadeh, R; Rai, P; Rizvi, I | 1 |
| Chauhan, SC; Kumar, A; Maher, DM; Palakurthi, S; Vangara, KK; Yellepeddi, VK | 1 |
| Arts, HJ; Bart, J; Crane, LM; de Jong, JS; Harlaar, NJ; Kelder, W; Low, PS; Ntziachristos, V; Pleijhuis, RG; Sarantopoulos, A; Themelis, G; van Dam, GM; van der Zee, AG | 1 |
| Kim, BG; Kim, YC; Lee, JH | 1 |
| Bardella, C; Coltella, N; Comoglio, PM; Di Renzo, MF; Fassetta, M; Filigheddu, N; Graziani, A; Nano, E; Rasola, A | 1 |
| Amandzholov, BS; Donenko, FV; Kiselevskii, MV; Sitdikova, SM | 1 |
| Balachandran, R; Curran, DP; Day, BW; Fukui, Y; Jung, WH; Madiraju, C; Montgomery, K; Raccor, BS; Shin, Y; Sikorski, RP; Vogt, A | 1 |
| Graeff, H; Harbeck, N; Höfler, H; Schmitt, M; Schüren, E; Yamamoto, N | 1 |
| Cornelisse, CJ; Corver, WE; Fleuren, GJ | 1 |
| Abeln, EC; Bonsing, BA; Cornelisse, CJ; Corver, WE; Fleuren, GJ; Vlak-Theil, PM | 1 |
| Amandzholov, BS; Chukanov, SV; Donenko, FV; Lebedin, IuS; Manziuk, LV; Moroz, LL; Sidtikova, SM; Toptygin, AIu | 1 |
| Acheson, N; Seymour, LW; Ward, CM | 1 |
| McQuarrie, SA; Mercer, JR; Miller, GG; Suresh, MR; Xiao, Z | 1 |
| Gupta, S; McQuarrie, SA; Mercer, JR; Miller, GG; Suresh, MR; Xiao, Z | 1 |
| Gilley-Pietsch, C; Heuser, LS; Miller, FN | 1 |
| Masood, S | 1 |
1 trial(s) available for fluorescein-5-isothiocyanate and Ovarian Neoplasms
| Article | Year |
|---|---|
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
Topics: Administration, Intravenous; Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; False Positive Reactions; Feasibility Studies; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folate Receptor 1; Folic Acid; Humans; Intraoperative Care; Luminescent Measurements; Middle Aged; Netherlands; Optical Imaging; Ovarian Neoplasms; Predictive Value of Tests; Reproducibility of Results | 2016 |
30 other study(ies) available for fluorescein-5-isothiocyanate and Ovarian Neoplasms
| Article | Year |
|---|---|
Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells.
Topics: Apoptosis; Calreticulin; Carcinoma, Ovarian Epithelial; Endoplasmic Reticulum Stress; Female; Fluorescein-5-isothiocyanate; Humans; Ovarian Neoplasms; Thapsigargin | 2022 |
Design of fluorophore-loaded human serum albumin nanoparticles for specific targeting of NIH:OVCAR3 ovarian cancer cells.
Topics: Cell Line, Tumor; Cell Survival; Estrogen Receptor alpha; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folic Acid; Humans; Indocyanine Green; Molecular Docking Simulation; Nanoparticles; Ovarian Neoplasms; Serum Albumin, Human; Up-Regulation | 2020 |
A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer.
Topics: Absorption; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Survival; Cetuximab; Endocytosis; ErbB Receptors; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescence; Humans; Immunoblotting; Immunotherapy; Liposomes; Molecular Targeted Therapy; Nanoparticles; Ovarian Neoplasms; Photochemotherapy; Porphyrins; Verteporfin | 2013 |
A simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: an in vitro study of targeted delivery of cisplatin to ovarian cancer cells.
Topics: Antibodies; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Delivery Systems; Female; Fluorescein-5-isothiocyanate; Humans; Hyaluronan Receptors; Lactic Acid; Maleimides; Microscopy, Confocal; Microscopy, Electron, Scanning; Ovarian Neoplasms; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2014 |
A Novel Intravital Imaging Window for Longitudinal Microscopy of the Mouse Ovary.
Topics: Animals; Collagen; Corpus Luteum; Dextrans; Extracellular Matrix; Female; Fluorescein-5-isothiocyanate; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Fluorescence, Multiphoton; Neoplasm Invasiveness; Oocytes; Ovarian Follicle; Ovarian Neoplasms; Ovulation; Tumor Microenvironment | 2015 |
Light-Controlled Delivery of Monoclonal Antibodies for Targeted Photoinactivation of Ki-67.
Topics: Antibodies, Monoclonal; Cell Nucleus; Cell Survival; Cysteamine; Endosomes; Female; Fluorescein-5-isothiocyanate; Humans; Ki-67 Antigen; Light; Liposomes; Molecular Targeted Therapy; Nuclear Localization Signals; Ovarian Neoplasms; Peptides; Photosensitizing Agents; Tumor Cells, Cultured | 2015 |
Virus-resembling nano-structures for near infrared fluorescence imaging of ovarian cancer HER2 receptors.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Bromovirus; Cell Line, Tumor; Dynamic Light Scattering; Female; Fluorescein-5-isothiocyanate; Humans; Immunohistochemistry; Indocyanine Green; Nanostructures; Ovarian Neoplasms; Receptor, ErbB-2; Spectrometry, Fluorescence; Spectroscopy, Near-Infrared | 2015 |
In Vitro/In Vivo Evaluation of Radiolabeled [(99m)Tc(CO)3](+)-Hydroxyurea and Fluorescein Isothiocyanate-Hydroxyurea.
Topics: Animals; Breast Neoplasms; Dextrans; Enzyme Inhibitors; Female; Fluorescein-5-isothiocyanate; Hydroxyurea; In Vitro Techniques; Male; Optical Imaging; Organotechnetium Compounds; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tumor Cells, Cultured | 2016 |
Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
Topics: A549 Cells; Acrylamides; Cell Line, Tumor; Cytoplasm; Endosomes; Female; Fluorescein-5-isothiocyanate; Gene Expression Regulation, Neoplastic; Gene Silencing; Gene Transfer Techniques; Humans; Microscopy, Confocal; Neoplasms; Oligopeptides; Ovarian Neoplasms; Peptides; Polymers; Real-Time Polymerase Chain Reaction; RNA; RNA Interference; RNA, Small Interfering; Surface Properties | 2016 |
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.
Topics: Case-Control Studies; Double-Blind Method; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folic Acid; Humans; KB Cells; Ligands; Male; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prostatic Neoplasms; Sensitivity and Specificity | 2008 |
pH-sensitive intracellular photoluminescence of carbon nanotube-fluorescein conjugates in human ovarian cancer cells.
Topics: Cell Line, Tumor; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Hydrolysis; Intracellular Space; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Nanotubes, Carbon; Ovarian Neoplasms; Spectrum Analysis, Raman | 2009 |
Multifunctional core-shell nanoparticles as highly efficient imaging and photosensitizing agents.
Topics: Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Fluorescein-5-isothiocyanate; Humans; Nanoparticles; Nanotechnology; Ovarian Neoplasms; Oxygen; Photochemistry; Photochemotherapy; Photosensitizing Agents; Silicon Dioxide; Spectrometry, Fluorescence | 2009 |
Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles.
Topics: Antibodies, Monoclonal; Ascitic Fluid; Cell Count; Cell Separation; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Magnetics; Microscopy, Fluorescence; Nanomedicine; Nanoparticles; Neoplasm Metastasis; Ovarian Neoplasms; Peptides | 2010 |
Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Nucleus; Dendrimers; Drug Carriers; Female; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Neoplasms; Ovarian Neoplasms; Polyamines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2010 |
Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer.
Topics: Antibodies, Monoclonal; Antibody Specificity; Cell Culture Techniques; Cell Line, Tumor; Cell Nucleolus; Cell Proliferation; Cell Survival; Epitopes; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Ki-67 Antigen; Liposomes; Microscopy, Confocal; Ovarian Neoplasms | 2010 |
Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT.
Topics: Biotinylation; Cell Death; Cell Line, Tumor; Cell Survival; Cisplatin; Dendrimers; Drug Delivery Systems; Female; Fluorescein-5-isothiocyanate; Gene Expression Regulation, Neoplastic; Hemolysis; Humans; Inhibitory Concentration 50; Intracellular Space; Materials Testing; Ovarian Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Symporters | 2011 |
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.
Topics: Aged; Diagnostic Imaging; Female; Fluorescein-5-isothiocyanate; Folate Receptor 1; Humans; Microscopy, Fluorescence; Middle Aged; Molecular Structure; Monitoring, Intraoperative; Ovarian Neoplasms | 2011 |
Thymosin β10 expression driven by the human TERT promoter induces ovarian cancer-specific apoptosis through ROS production.
Topics: Actins; Adenoviridae; Annexin A5; Antineoplastic Agents; Apoptosis; Cell Movement; Cisplatin; DNA Primers; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genetic Therapy; Humans; Immunohistochemistry; Membrane Potential, Mitochondrial; Neoplasm Invasiveness; Ovarian Neoplasms; Paclitaxel; Promoter Regions, Genetic; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Telomerase; Thymosin | 2012 |
p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis.
Topics: Adenocarcinoma; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Chromones; Cisplatin; Female; Flavonoids; Flow Cytometry; Fluorescein-5-isothiocyanate; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Morpholines; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Protein Kinase Inhibitors; Rhodamines | 2006 |
Lectin binding to mouse blood lymphocytes during tumor growth.
Topics: Acetylgalactosamine; Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Lectins; Lymphocytes; Male; Mannose; Mice; Mice, Inbred C57BL; Ovarian Neoplasms; Plant Lectins | 2005 |
Cell-based and biochemical structure-activity analyses of analogs of the microtubule stabilizer dictyostatin.
Topics: Alkanes; Animals; Benzimidazoles; Binding Sites; Brain Chemistry; Carbamates; Carcinoma; Cattle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Epothilones; Female; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; G2 Phase; HeLa Cells; Histones; Humans; Kinetics; Lactones; Macrolides; Microtubules; Molecular Structure; Ovarian Neoplasms; Paclitaxel; Phosphorylation; Protein Binding; Pyrones; Quantitative Structure-Activity Relationship; Radioligand Assay; Tubulin; Tubulin Modulators | 2008 |
[Development of a technique for isolation of intact tumor cells from fresh breast or ovarian cancer tissue. Use in analysis of tumor-associated proteolytic factors].
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Cycle; Cell Separation; DNA, Neoplasm; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Ovarian Neoplasms; Peptide Hydrolases; Ploidies; Tumor Cells, Cultured | 1993 |
Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan.
Topics: Antibodies, Monoclonal; Antigens; Antigens, Neoplasm; Antigens, Surface; DNA; DNA, Neoplasm; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Intermediate Filament Proteins; Neoplasm Proteins; Ovarian Neoplasms; Phycoerythrin; Propidium; Signal Processing, Computer-Assisted; Tumor Cells, Cultured | 1994 |
One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.
Topics: Biomarkers; Cell Survival; Coloring Agents; DNA, Neoplasm; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Genetic Heterogeneity; Humans; Intermediate Filaments; Lasers; Neoplasms; Ovarian Neoplasms; Phenotype; Phycoerythrin; Ploidies; Proliferating Cell Nuclear Antigen; Propidium; Staining and Labeling | 1996 |
[Interaction of natural autoantibodies to human ovarian tumor associated antigen with ovarian cancer cells from CaO-1 mice].
Topics: Animals; Antigens, Neoplasm; Autoantibodies; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Tumor Cells, Cultured | 1999 |
Folic acid targeting of protein conjugates into ascites tumour cells from ovarian cancer patients.
Topics: Ascites; DNA; Drug Delivery Systems; Female; Fluorescein-5-isothiocyanate; Folic Acid; Genetic Therapy; Humans; Ovarian Neoplasms; Peritoneum; Serum Albumin, Bovine; Tumor Cells, Cultured | 2000 |
Modern trends in radioimmunotherapy of cancer: pretargeting strategies for the treatment of ovarian cancer.
Topics: Antibodies, Monoclonal; Female; Fluorescein-5-isothiocyanate; Humans; Liposomes; Ovarian Neoplasms; Radioimmunotherapy; Tumor Cells, Cultured | 2001 |
A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitro.
Topics: Antibodies, Monoclonal; Biotinylation; CA-125 Antigen; Carcinoma; Female; Fluorescein-5-isothiocyanate; Humans; Kinetics; Liposomes; Ovarian Neoplasms; Radioimmunotherapy; Streptavidin; Tumor Cells, Cultured | 2002 |
Protein leak from normal vasculature due to human malignant ascites.
Topics: Adenocarcinoma; Animals; Ascites; Ascitic Fluid; Blood Proteins; Capillary Permeability; Edetic Acid; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Hydrogen-Ion Concentration; Isotonic Solutions; Male; Microcirculation; Microscopy, Fluorescence; Ovarian Neoplasms; Peritoneum; Plasma; Rats; Rats, Inbred Strains; Thiocyanates | 1988 |
The potential value of imprint cytology in cytochemical localization of steroid hormone receptors in ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma; Cytological Techniques; Endometriosis; Estradiol; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Histocytochemistry; Humans; Microscopy, Fluorescence; Middle Aged; Ovarian Neoplasms; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Rhodamines; Serum Albumin, Bovine | 1988 |